Skip to content
  • Facebook
  • Twitter
This translation is automatically provided by Google; please refer to the original English version for appropriate wording.
Take on Typhoid

Take on Typhoid

  • Home
  • Why Typhoid?
    • Typhoid & Related Salmonelloses
    • Global Research
    • Links & Resources
  • The Issues
    • Vaccines
    • WASH
    • Drug-Resistant Typhoid
    • Treatment
    • Diagnostics
    • Typhoid intestinal perforation
    • Related Issues
  • Resources & Tools
    • Talk About Typhoid
    • Global Policy
    • Country Tools
    • Infographics
    • Fact Sheets
    • TCV Cost-effectiveness
    • Share on Social
  • Blog & News
    • Blog
    • News
    • Publications
    • Newsletter
  • International Conference
    • Past Conferences
    • Conference Travel
  • About Us
    • About the Coalition against Typhoid
    • About the Typhoid Vaccine Acceleration Consortium

New trial investigates typhoid conjugate vaccine in Africa

Posted on February 28, 2018 by admin
  • The Typhoid Vaccine Acceleration Consortium, or TyVAC, recently launched a trial assessing the effectiveness and cost-effectiveness of the new typhoid conjugate vaccine, Typbar TCV®, among children in Malawi

Post navigation

Malawi is first African nation using new WHO approved typhoid vaccine
Increased Diagnoses of Typhoid Fever, Shigellosis Linked to SE Asia Visits

Newsletter Signup

Recent Posts

  • Three things to know about typhoid and drug resistance

  • Humanly possible: The people making vaccine introductions a reality

  • L’humain au cœur de l’introduction des vaccins

  • Data collection in Cambodia: Ensuring high-quality data to support decision-making

  • Data collection in Burkina Faso: Coordinating local partners to gather data on typhoid burden

cat
685 West Baltimore Street, Room 480
Baltimore, MD 21201-1509
Coalition against Typhoid
2000 Pennsylvania Ave, NW, Suite 7000
Washington, DC 20006
© 2018. Coalition Against Typhoid. All Rights Reserved.
  • Contact Us
  • Privacy Policy
  • Facebook
  • Twitter
Top